Atlas Trials

A Study of the Effectiveness and Safety of Risperidone Compared With Haloperidol and Placebo in Patients With Chronic Schizophrenia

Clinical trial NCT00249132 · COMPLETED

Trial details

NCT number
NCT00249132
Sponsor
Janssen, LP
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
SchizophreniaPsychotic Disorders
Enrollment
523

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.